MAM
YARW

Meeder Asset Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Meeder Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed -$15K – 2502
2020
Q1 		$15K Buy
+1
New +$15.7K ﹤0.01% 1365
2019
Q4 		– Hold
0
– – – 1948
2019
Q3 		– Hold
0
– – – 1837
2019
Q2 		– Hold
0
– – – 1746
2019
Q1 		– Hold
0
– – – 1330
2018
Q4 		– Hold
0
– – – 1424
2018
Q3 		– Hold
0
– – – 1194

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's YARW Position: Q2 2020 in Review

Meeder Asset Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2020, closing a stake of 1 share — an estimated $15K sold.

Meeder Asset Management first reported a position in YARW in Q1 2020 and held it in 1 quarter. The position peaked at $15K in Q1 2020. 98 funds tracked by Wall St. Rank hold YARW as of Q2 2020.

  • Meeder Asset Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 1 Yarrow Bioscience, Inc. Common Stock share in Q2 2020, an estimated $15K.
  • Meeder Asset Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Meeder Asset Management's Yarrow Bioscience, Inc. Common Stock position peaked at $15K in Q1 2020.
  • 98 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.